Misinformation, hesitancy could blunt impact of new cancer vaccines

Misinformation and vaccine hesitancy could significantly blunt the impact of new cancer vaccines. Many observers point to the opposition and wild conspiracy theories surrounding the human papillomavirus vaccine as a cautionary tale. These factors create barriers to widespread adoption and effectiveness, mirroring previous challenges faced with HPV vaccinations. Ensuring public trust is critical to prevent similar patterns of resistance from undermining the potential benefits and deployment of these innovative cancer-fighting medical advancements.